Nyla J Courter, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9786 W Delphi Pike 27, Converse, IN 46919 Phone: 765-395-3555 Fax: 765-395-3141 |
News Archive
BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix's nanoscale whole genome imaging and analysis platform.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has completed its targeted enrollment of Phase III clinical trials for CM-AT, its autism treatment.
The politically charged Wednesday vote on repealing the health overhaul will mark the first step for Republicans in their effort to use a variety of legislative tools to undo the new federal health law. Meanwhile, almost immediately after the vote, House committees will begin considering targeted parts of health law. But some news outlets check the facts regarding a key part of the GOP argument against the measure — that it is a job killer.
Researchers at The Rockefeller University Hospital have begun a clinical study to explore a possible connection between vitamin D deficiency and insulin resistance.
MassBiologics of the University of Massachusetts Medical School and Merck & Co., Inc. announced today that they have entered into an agreement that provides Merck with exclusive rights to market and distribute MBL's tetanus and diphtheria toxoids adsorbed (Td) vaccine in the United States, with the exception of Massachusetts, where MBL will continue distributing the vaccine.
› Verified 7 days ago